UNITED version 2 (23-Jan-2018)

• Research type

  Research Study

• Full title

  Uniform Noting for International application of the Tumour-stroma ratio as Easy Diagnostic tool

• IRAS ID

  248878

• Contact name

  AGH Roodvoets

• Contact email

  datacenter@lumc.nl

• Sponsor organisation

  Leiden University Medical Center

• Clinicaltrials.gov Identifier

  NTR7270, Nederlands trial register

• Duration of Study in the UK

  4 years, 9 months, 1 days

• Research summary

  The tumour-stroma ratio (TSR) is based on the amount of stroma within the primary tumour. Several studies have shown promising results of the TSR to predict disease free and overall survival for patients with colon carcinoma stage II and III. The TSR, combined with current routine histological data, might open a way to improve personalized treatment of patients with colon carcinoma.

• REC name

  North East - York Research Ethics Committee

• REC reference

  18/NE/0334

• Date of REC Opinion

  19 Oct 2018

• REC opinion

  Favourable Opinion